Biomedical Sciences Blog

The Leukemia & Lymphoma Society's (LLS) Translational Research Program (TRP) was established to encourage and provide support for new and novel clinical research. The goal of the program is to accelerate transfer of findings from the laboratory to clinical application. The program's purpose is to fund research that shows high promise for translating basic biomedical knowledge to prevention or new treatments and, ultimately, to prolong and enhance life.

A renewal of the grant may be funded for an additional two years if it includes an approved clinical trial and a fully justified research plan. A principal intent of the program is to permit the acquisition of sufficient data to apply to an appropriate agency or sponsor for sustained support.

Awards will be limited to a maximum of $200,000, which include direct costs and a maximum overhead of $20,000 or 11.1 percent of direct costs per year for three years. Budget requests should be carefully justified and commensurate with the needs of the project.

Deadlines
A letter of intent is mandatory for those applying for a TRP grant and must be completed online via proposalCentral by 3 p.m. ET, March 1, . Full applications must be received electronically via proposalCentral by 3 p.m. ET, March 15.

If any of the deadlines fall on a Saturday or Sunday, the applications are due the next business day.

This program is now open for 2011 submssion.

For more program information, contact:
The Leukemia & Lymphoma Society
1311 Mamaroneck Ave.
White Plains, NY 10605
Telephone: (914) 821-8301/ 8290
or Email: researchprograms@lls.org

# posted by BIOENGINE @ 11:56 PM